JPY 927.0
(-0.22%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 4.31 Billion JPY | 4.17% |
2022 | 4.14 Billion JPY | 7.43% |
2021 | 3.85 Billion JPY | -0.36% |
2020 | 3.86 Billion JPY | -2.84% |
2019 | 3.98 Billion JPY | -8.48% |
2018 | 4.35 Billion JPY | -0.89% |
2017 | 4.39 Billion JPY | -12.32% |
2016 | 5 Billion JPY | 23.71% |
2015 | 4.04 Billion JPY | -19.19% |
2014 | 5 Billion JPY | -1.44% |
2013 | 5.08 Billion JPY | 0.97% |
2012 | 5.03 Billion JPY | 18.46% |
2011 | 4.24 Billion JPY | 6.56% |
2010 | 3.98 Billion JPY | 4.89% |
2009 | 3.8 Billion JPY | 3.07% |
2008 | 3.68 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 4.14 Billion JPY | 2.19% |
2024 Q1 | 4.05 Billion JPY | -6.07% |
2024 Q3 | 3.8 Billion JPY | -8.1% |
2023 Q3 | 4.16 Billion JPY | 2.82% |
2023 Q4 | 4.31 Billion JPY | 3.47% |
2023 FY | 4.31 Billion JPY | 4.17% |
2023 Q1 | 4.06 Billion JPY | -1.75% |
2023 Q2 | 4.05 Billion JPY | -0.34% |
2022 Q1 | 4.05 Billion JPY | 5.15% |
2022 Q3 | 4.13 Billion JPY | 2.59% |
2022 Q4 | 4.14 Billion JPY | 0.14% |
2022 FY | 4.14 Billion JPY | 7.43% |
2022 Q2 | 4.03 Billion JPY | -0.56% |
2021 Q1 | 3.72 Billion JPY | -3.63% |
2021 Q3 | 3.64 Billion JPY | -11.26% |
2021 Q4 | 3.85 Billion JPY | 5.89% |
2021 FY | 3.85 Billion JPY | -0.36% |
2021 Q2 | 4.1 Billion JPY | 10.04% |
2020 FY | 3.86 Billion JPY | -2.84% |
2020 Q2 | 3.99 Billion JPY | 2.79% |
2020 Q3 | 3.81 Billion JPY | -4.58% |
2020 Q4 | 3.86 Billion JPY | 1.41% |
2020 Q1 | 3.89 Billion JPY | -2.32% |
2019 Q2 | 4.19 Billion JPY | 0.81% |
2019 Q3 | 3.88 Billion JPY | -7.36% |
2019 FY | 3.98 Billion JPY | -8.48% |
2019 Q4 | 3.98 Billion JPY | 2.58% |
2019 Q1 | 4.15 Billion JPY | -4.46% |
2018 Q4 | 4.35 Billion JPY | -1.19% |
2018 Q3 | 4.4 Billion JPY | -2.17% |
2018 FY | 4.35 Billion JPY | -0.89% |
2018 Q1 | 4.55 Billion JPY | 3.85% |
2018 Q2 | 4.5 Billion JPY | -1.27% |
2017 Q1 | 4.59 Billion JPY | -8.24% |
2017 Q4 | 4.39 Billion JPY | -3.69% |
2017 Q3 | 4.55 Billion JPY | -3.28% |
2017 FY | 4.39 Billion JPY | -12.32% |
2017 Q2 | 4.71 Billion JPY | 2.57% |
2016 Q3 | 4.41 Billion JPY | -4.79% |
2016 FY | 5 Billion JPY | 23.71% |
2016 Q4 | 5 Billion JPY | 13.39% |
2016 Q2 | 4.63 Billion JPY | 2.89% |
2016 Q1 | 4.5 Billion JPY | 11.37% |
2015 Q1 | 4.18 Billion JPY | -16.52% |
2015 Q2 | 4.22 Billion JPY | 1.07% |
2015 Q4 | 4.04 Billion JPY | 4.25% |
2015 Q3 | 3.88 Billion JPY | -8.13% |
2015 FY | 4.04 Billion JPY | -19.19% |
2014 Q2 | 4.76 Billion JPY | 4.01% |
2014 FY | 5 Billion JPY | -1.44% |
2014 Q4 | 5 Billion JPY | 6.27% |
2014 Q3 | 4.71 Billion JPY | -1.11% |
2014 Q1 | 4.58 Billion JPY | -9.83% |
2013 Q2 | 5.57 Billion JPY | 4.26% |
2013 Q3 | 4.95 Billion JPY | -11.12% |
2013 Q4 | 5.08 Billion JPY | 2.57% |
2013 FY | 5.08 Billion JPY | 0.97% |
2013 Q1 | 5.34 Billion JPY | 6.22% |
2012 Q3 | 4.91 Billion JPY | -3.53% |
2012 FY | 5.03 Billion JPY | 18.46% |
2012 Q2 | 5.09 Billion JPY | 2.5% |
2012 Q1 | 4.97 Billion JPY | 17.09% |
2012 Q4 | 5.03 Billion JPY | 2.31% |
2011 Q1 | 3.81 Billion JPY | -4.36% |
2011 Q2 | 4.08 Billion JPY | 7.18% |
2011 Q3 | 3.85 Billion JPY | -5.75% |
2011 FY | 4.24 Billion JPY | 6.56% |
2011 Q4 | 4.24 Billion JPY | 10.29% |
2010 Q4 | 3.98 Billion JPY | 8.74% |
2010 FY | 3.98 Billion JPY | 4.89% |
2010 Q3 | 3.66 Billion JPY | -4.88% |
2010 Q1 | 3.64 Billion JPY | -4.22% |
2010 Q2 | 3.85 Billion JPY | 5.88% |
2009 Q1 | 3.55 Billion JPY | 0.0% |
2009 Q2 | 3.79 Billion JPY | 6.81% |
2009 FY | 3.8 Billion JPY | 3.07% |
2009 Q3 | 3.58 Billion JPY | -5.75% |
2009 Q4 | 3.8 Billion JPY | 6.17% |
2008 FY | 3.68 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
DVx Inc. | 13.48 Billion JPY | 67.994% |
Seikagaku Corporation | 11.3 Billion JPY | 61.85% |
Eiken Chemical Co., Ltd. | 15.67 Billion JPY | 72.483% |
PHC Holdings Corporation | 425.15 Billion JPY | 98.985% |
Techno Medica Co., Ltd. | 3.61 Billion JPY | -19.338% |
Rion Co., Ltd. | 8.2 Billion JPY | 47.4% |
Nihon Kohden Corporation | 52.14 Billion JPY | 91.727% |
Fukuda Denshi Co., Ltd. | 42.46 Billion JPY | 89.841% |
Japan Lifeline Co., Ltd. | 15.58 Billion JPY | 72.308% |
Japan Medical Dynamic Marketing, INC. | 5.88 Billion JPY | 26.651% |
3-D Matrix, Ltd. | 5.53 Billion JPY | 22.024% |
CYBERDYNE Inc. | 9.52 Billion JPY | 54.695% |